TRPC6 inhibition: podocyte-targeted treatment for focal segmental glomerulosclerosis?

The Lancet 2026

View at publisher

Authors: Marina Vivarelli, Priya S. Verghese

DOI: 10.1016/s0140-6736(25)02606-6

Cited by: 0

References: 5

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Complement system in diseases

References 5